Overall treatment effect and contextual effect of osteoarthritis treatments: meta-analysis of randomized clinical trials
Weiya Zhang, BM, MPH, PhD (Nottingham, UK)
Drug use and risk of comorbidities in osteoarthritis
Philip Conaghan, MB BS, PhD, FRACP, FRCP (Leeds, UK)
Chondroitin sulphate for hand osteoarthritis: a randomized, placebo-controlled trial in primary care: the FACTUAL study
George Peat, PhD, MCSP (Keele, UK)
MOSAIC: 24 MOnth study on Structural changes in knee osteoarthritis Assessed by mrI with Chondroitin sulphate
Jean-Pierre Pelletier, MD (Montreal, Quebec, Canada)
Long-term effects of treatment on the progression of structural changes in knee osteoarthritis: new follow-up data from the Osteoarthritis Initiative cohort
Johanne Martel-Pelletier, PhD (Montreal, Quebec, Canada)
Long term use of analgesics and risk of osteoarthritis progression and knee replacement from the Osteoarthritis Initiative cohort.
Ali Guermazi, MD, PhD (Boston, MA, USA)
Question and answer session
Any doubt? Contact us and we will write you as soon as posible.
By sending this form, I agree that the information will be used only by Bioiberica and its contracted third-parties to email me helpful information on Osteoarthritis, CS b-Bioactive and related treatments, products and services, and for marketing and informational purposes. To be removed from our mailing list or request a copy of this information, contact us at firstname.lastname@example.org. I accept liability for the information I have provided.
* This website is not intended to report adverse events related to Bioiberica's products. If you would like to report a suspected adverse reaction, please contact the Department of Pharmacovigilance Bioiberica.